Bayesian Capital Management LP Invests $1.52 Million in Aflac Incorporated (NYSE:AFL)

Bayesian Capital Management LP bought a new position in Aflac Incorporated (NYSE:AFL - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 14,700 shares of the financial services provider's stock, valued at approximately $1,521,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Whipplewood Advisors LLC acquired a new position in Aflac during the 4th quarter worth about $26,000. BankPlus Trust Department acquired a new stake in shares of Aflac in the 4th quarter valued at about $34,000. Curio Wealth LLC bought a new stake in Aflac in the 4th quarter valued at approximately $36,000. OFI Invest Asset Management acquired a new position in shares of Aflac during the 4th quarter worth about $38,000. Finally, Rialto Wealth Management LLC bought a new position in Aflac in the fourth quarter valued at approximately $41,000. 67.44% of the stock is owned by institutional investors.

Insider Activity at Aflac

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the transaction, the director now directly owns 25,393 shares in the company, valued at $2,733,048.59. This trade represents a 3.79 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the transaction, the director now directly owns 49,962 shares in the company, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by corporate insiders.

Aflac Stock Down 0.6 %

Shares of AFL traded down $0.69 on Thursday, reaching $106.27. The company's stock had a trading volume of 1,926,220 shares, compared to its average volume of 2,103,355. Aflac Incorporated has a twelve month low of $84.30 and a twelve month high of $115.50. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The firm has a fifty day moving average of $107.32 and a 200-day moving average of $106.76. The stock has a market capitalization of $58.00 billion, a PE ratio of 11.07, a PEG ratio of 3.24 and a beta of 0.84.

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The business had revenue of $3.40 billion during the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a net margin of 28.76% and a return on equity of 16.20%. The firm's revenue for the quarter was down 37.5% compared to the same quarter last year. During the same quarter last year, the company earned $1.66 EPS. Equities analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st will be given a $0.58 dividend. This represents a $2.32 annualized dividend and a dividend yield of 2.18%. The ex-dividend date of this dividend is Wednesday, May 21st. Aflac's dividend payout ratio (DPR) is currently 36.25%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on AFL shares. Piper Sandler boosted their price target on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. BMO Capital Markets assumed coverage on shares of Aflac in a report on Thursday, January 23rd. They set a "market perform" rating and a $111.00 price target for the company. Keefe, Bruyette & Woods lifted their target price on Aflac from $104.00 to $106.00 and gave the company a "market perform" rating in a research report on Wednesday. Wells Fargo & Company boosted their price objective on Aflac from $102.00 to $103.00 and gave the stock an "equal weight" rating in a research report on Tuesday. Finally, JPMorgan Chase & Co. boosted their target price on shares of Aflac from $94.00 to $96.00 and gave the stock a "neutral" rating in a report on Wednesday, April 2nd. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $104.21.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.